Ligand validation:2VDO

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VDO_GOL_B_1462	48%	88%	0.185	0.928	0.4	0.27	-	-	0	0	100%	1
2VDO_GOL_A_1453	42%	91%	0.174	0.894	0.47	0.1	-	-	0	0	100%	1
7U60_GOL_A_505	84%	49%	0.087	0.948	0.88	1.09	-	-	0	0	100%	1
2VDP_GOL_A_1453	65%	89%	0.128	0.928	0.44	0.2	-	-	0	0	100%	1
2VC2_GOL_B_1478	62%	89%	0.183	0.976	0.36	0.28	-	-	0	0	100%	1
2VDN_GOL_A_1453	53%	90%	0.181	0.943	0.37	0.25	-	-	0	0	100%	1
2VDQ_GOL_B_1462	52%	86%	0.157	0.916	0.35	0.37	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
4Q6J_GOL_A_306	100%	33%	0.026	0.995	0.71	1.9	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.